Get startedLog in
    Picture of SpringWorks Therapeutics logo

    SWTX — SpringWorks Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    All News

    Brief: Springworks Got Notice Of Termination Of Amended & Restated Collaboration And License Agreement Between Co & GSK

    Picture of SpringWorks Therapeutics logoSpringWorks Therapeutics
    07/06/2024 21:51
    June 7 (Reuters) - GSK plc  GSK.L :
    * SPRINGWORKS THERAPEUTICS:GOT NOTICE OF TERMINATION OF
AMENDED &
RESTATED COLLABORATION AND LICENSE AGREEMENT, DATED SEPT 6,
2022, BETWEEN CO & GSK
    * SPRINGWORKS THERAPEUTICS:DEAL TERMINATION BETWEEN CO &
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT EFFECTIVE 180
DAYS AFTER NOTICE RECEIPT
    * SPRINGWORKS THERAPEUTICS INC - TERMINATION DOES NOT AFFECT
CO'S
RIGHTS TO CONTINUE DEVELOPING OR COMMERCIALIZING ITS PRODUCTS OR
PRODUCT CANDIDATES
    * SPRINGWORKS THERAPEUTICS INC - CO EXPECTS THAT GSK WILL
CONTINUE
ONGOING CLINICAL TRIALS UNDER LICENSE AGREEMENT
    * SPRINGWORKS THERAPEUTICS INC - TERMINATION OF LICENSE DEAL
DOES
NOT TRIGGER ANY PAYMENT OBLIGATIONS ON PART OF CO/ANY OTHER
MATERIAL WIND-DOWN COSTS

Source text for Eikon:  ID:n0001104659-24-069653 
Further company coverage:  GSK.L 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on SpringWorks Therapeutics

    See all news